Effect of Unani formulations in knee ostioarthritis
- Conditions
- Health Condition 1: M179- Osteoarthritis of knee, unspecified
- Registration Number
- CTRI/2024/07/070116
- Lead Sponsor
- ational Institute of Unani Medicine, Bengaluru
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Diagnosed cases of OA Knee Joint as per ACR Criteria16 (clinical, radiographical and laboratory).
2.Subjects of all genders aged 45-70 years.
3.Grade I and II of Kellgren Lawrence grading scale17
1.Subjects who experience a rapid worsening of knee symptoms, have a hot swollen knee, have a previous knee replacement on the affected knee, have a history of significant trauma to the affected knee, have a joint injection or arthroscopy in the past 6 months, or have any major surgery in the last year.
2.Subjects currently taking, or in the past 3 months were taking, pain-relieving medications (e.g., nonsteroidal anti-inflammatory drugs, analgesics, and corticosteroids).
3.Subjects diagnosed with gout or pseudo gout within the last 3 months, have a history of gout in the knee joint, diagnosed with other inflammatory arthritis (e.g., rheumatoid arthritis, septic arthritis), and malignancy, diagnosed with a complex pain disorder or severe immobility (e.g., complex regional pain syndrome, severe back pain, multiple sclerosis, muscular dystrophy, Parkinson’s disease, or hemiplegia).
4.Participants with a recent diagnosis of, and/or currently suffering from uncontrolled medical conditions including but not limited to diabetes (RBS=180mg/dl), hypertension (=140/90mmHg), cardiovascular disease gall bladder disease/gallstones/biliary disease, endocrine disease, or malignancies.
5.Pregnant and lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method